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INTRODUCTION: 
 
DEVELOPMENT OF THE BILIARY SYSTEM 
 
The liver develops from an endodermal bud in the ventral floor of the 
foregut at about 22 days' gestation. One type of endodermal cell in the 
cranial portion of the liver diverticulum serves as a common precursor for 
both hepatocytes and the intrahepatic and hilar bile ducts. Immature 
hepatocytes, or hepatoblasts, are derived from these early cells and retain the 
potential to differentiate into either hepatocytes or intrahepatic ducts. These 
cells may persist as a facultative stem cell and can be stimulated to 
proliferate and differentiate under certain pathologic conditions. 
At about 2 months' gestation, primitive intrahepatic bile ducts can be 
distinguished from early hepatocytes by their tendency to form a sleeve 
around portal venous branches and associated mesenchyme. This sleeve is 
termed the ductal plate. Portions of the sleeve are duplicated, forming small 
linear tubules that differentiate into bile ducts. This process begins at the 
liver hilum and extends peripherally into the segmental distribution of the 
developing liver. At the hilum, connection is made to the extra hepatic bile 
ducts. Formation of the major branches of the biliary tree is completed by 10 
to 12 weeks' gestation, but the peripheral branches continue developing 
throughout gestation. 
The development of the distal common bile duct and pancreaticobiliary 
junction is particularly relevant to pediatric surgeons. During the fifth week 
of gestation, the dorsal and ventral pancreatic buds appear. The dorsal bud 
forms the body of the pancreas and empties through what will become the 
accessory pancreatic duct (Santorini) into the duodenum. The ventral bud 
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arises from the distal common bile duct, rotates dorsally to join the body of 
the pancreas as the uncinate process, and empties through the main 
pancreatic duct (Wirsung) into the common bile duct. During normal 
development, the junction between the main pancreatic duct and the 
common bile duct migrates distally through the duodenal wall to unite 
within the sphincter of Oddi at the ampulla. Abnormalities in this process 
account for a variety of anatomically based biliary disorders of childhood. 
Physiologic Maturation: 
The hepatocyte performs a multitude of essential physiologic tasks. These 
include production of plasma proteins, gluconeogenesis and glycogenolysis, 
biotransformation of toxins and chemicals, bile acid metabolism and 
cholesterol regulation, and bilirubin excretion. During gestation, many of 
these functions are performed for the fetus through placental transport and 
maternal hepatic function. Many of the excretory functions of the fetal liver 
mature only after birth. The physiologic immaturity of the newborn liver 
undoubtedly contributes to the pathophysiology of several neonatal diseases 
characterized by abnormal bile composition or flow. 
Bile acids are formed in the liver by stereospecific additions and 
modifications of cholesterol. Bile acid metabolism is a critical determinant 
of cholesterol regulation and intestinal absorption of dietary fat. 
The enterohepatic circulation maintains the bile acid pool by recycling 
excreted bile acids. This occurs through a sodium “bile acid cotransport 
system present on the ileal brush border. The bile acids then return to the 
liver through the portal circulation, where they are actively secreted by a 
second sodium “bile acid cotransporter across the hepatocyte canalicular 
membrane. Bacteria present in the jejunum and ileum metabolize a portion 
of the primary bile acids to secondary bile acids (deoxycholic acid, 
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ursodeoxycholic acid, and lithocholic acid), which are passively absorbed in 
the colon and reenter the hepatic circulation. Lithocholate can be hepatotoxic 
and may contribute to  the liver damage associated with various types of 
cholestasis. 
Bile acids are first detected in human fetuses at about 14 weeks' gestation. 
The bile acid pool increases in late gestation, but remains relatively smaller 
in children than adults. Despite decreased bile acid pool size and diminished 
intestinal absorption, serum bile acids remain elevated in human infants 
younger than 6 months of age, implying ineffective hepatic clearance. Thus, 
the newborn infant is relatively predisposed to cholestasis. 
Most bilirubin is the product of heme degradation derived from effete 
erythrocytes. Erythrocyte half-life is shorter in the fetus and neonate; 
therefore, production of unconjugated bilirubin is relatively greater than in 
the adult. Most pigment is transferred unaltered across the placenta to the 
maternal circulation. Bilirubin uridine 5α diphosphate (UDP)-
glucuronyltransferase, which conjugates bilirubin, is first detected at about 
20 weeks' gestation, but its activity remains low until after birth. The serum 
bilirubin concentration normally peaks on the third to fifth day of life in full-
term newborns and gradually declines to adult levels thereafter. Bacterial 
flora responsible for the conversion of conjugated bilirubin to urobilin is 
absent or reduced in the newborn gut, which allows the enzyme β -
glucuronidase to deconjugate the accumulated bilirubin. This results in the 
absorption of a significant load of unconjugated bilirubin from the newborn 
intestine and accounts for the increased jaundice seen when there is delayed 
passage of meconium or intestinal obstruction. 
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 Prenatal Detection: 
With the use of prenatal ultrasonography, an increasing number of CDCs 
have been reported in the foetus. The prenatal demonstration of a cystic 
structure inferior to the liver strongly suggests the diagnosis. Foetal 
development should be carefully monitored with serial ultrasonography after 
such a discovery. Most centres prefer to excise the cyst shortly after birth. A 
waiting period of a few weeks is necessary to stabilize the 
baby and allow for proper preoperative evaluation. Surgical excision in the 
neonatal period has been shown to be technically feasible and well tolerated 
by the patient. 
NORMAL HEPATOCYTE METABOLISM: 
The hepatocyte is the most abundant cell type in the liver. It is responsible 
for most of its metabolic functions and is the target cell of many diseases. 
Both acquired and congenital diseases of the liver affect hepatocytes. Liver-
based metabolic diseases are numerous and often result from the abnormal 
expression of a single gene in hepatocytes. This chapter presents important 
structural aspects of hepatocyte function; discusses the role of hepatocytes 
in the metabolism of carbohydrates, proteins, fat, and other molecules; and 
focuses on mechanisms of dysfunction and injury, such as apoptosis, 
necrosis, and regeneration. Hepatocyte transplant is also discussed as a 
model of function and dysfunction.  
STRUCTURAL BASIS 
FOR HEPATOCYTE FUNCTION 
The liver, the cradle of the soul according to the ancient Greeks, is the 
largest organ in the body, weighing 2 to 2.5% of total body weight. A closer 
approximation for liver weight for transplant has been developed as 772 × 
body surface area (– 38 if less than 1 m² ). If hepatocytes are isolated 
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from the liver, each gram of tissue yields an average of approximately 50 
million hepatocytes. A human left liver lobe, for example, contains, in 
general, over 10 billion hepatocytes. Hepatocytes constitute approximately 
60% of the total cells in the liver. The other 40% are called nonparenchymal 
cells and include macrophage-derived Kupffer cells, which are important in 
host defense and mediators of the inflammatory response; fenestrated 
endothelial cells; lymphocytes; and the stellate cell, which is responsible 
for the synthesis of extracellular collagen in response to liver and hepatocyte 
injury. Hepatocytes provide a selective barrier between the external and 
internal milieu by cementing themselves with gap and tight junctions, which, 
in turn, provide polarity and restrict distinct activities to three separate 
membrane domains: basolateral, apical, and lateral. At the basolateral 
(sinusoidal) membrane, hepatocytes exchange metabolites with the blood. At 
the apical (canalicular) membrane, hepatocytes secrete bile, detoxified waste 
products, cholesterol, and phospholipids. The bile canaliculi are formed by 
the tight junction–bound apical membranes and are the earliest component 
of the bile drainage system. Disruption of tight junctions can permit leakage 
of bile from canaliculi into the sinusoids and circulation. The lateral 
membrane is the surface between adjacent hepatocytes. Gap junctions permit 
attachment between hepatocytes and nerve impulse transmission between 
hepatocyte acinar zones. 
HEPATOCYTE LOBULE 
Two models exist of hepatic organization: the lobule and the acinus. The 
lobules have a central vein, a portal area, and liver plates that converge from 
portal area to central vein. The portal space at the periphery of the lobule 
contains a hepatic arteriole, a portal venule, a bile ductule, nerves, and 
lymphatics. Lobules are cylindrical structures measuring several millimetres 
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in length and 1 to 2 mm in diameter. The human liver contains 
approximately 50,000 individual lobules. Blood enters the lobule from 
the portal area, traverses the hepatic sinusoids, and is collected into the 
central veins toward which the hepatic cellular plates converge . Central 
veins join and drain into the hepatic veins and subsequently into 
the right atrium of the heart. 
ACINAR ZONAL DIFFERENTIATION 
The simple liver acinus is arranged around an axis containing the hepatic 
arteriole, portal venule, and ductile that grows out from one portal area. 
Hepatocytes vary in their metabolic functions depending on their location 
within the hepatic lobule. Periportal hepatocytes (zone 1) receive blood rich 
in oxygen and nutrients from the portal venules and hepatic arterioles. 
Pericentral hepatocytes (zone 3) receive blood that has already traversed 
most of the sinusoid and is thus lower in nutrients and oxygen and higher in 
waste products. These differences result in variations in hepatocyte 
Synthetic function, proliferative potential, ability to detoxify substances, and 
susceptibility to drug or ischemia injury. Periportal hepatocytes specialize in 
oxidative metabolism, whereas pericentral hepatocytes detoxify drugs. The 
periportal hepatocytes are also predominantly responsible for converting 
ammonia to urea by the concerted action of the urea cycle enzymes. This is a 
high capacity, low-affinity system, and because periportal cells also generate 
ammonia from deamination of amino acids, ammonia reaches the pericentral 
hepatocytes. Pericentral hepatocytes exclusively express glutamine 
synthetase and can uptake this ammonia to synthesize glutamine. Thus, 
Pericentral hepatocytes scavenge ammonia with high affinity, convert it to 
glutamine, and prevent toxic ammonia from reaching the systemic 
circulation. 
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LIVER CELLULAR STRUCTURE 
Hepatic plates are usually two cells thick and are bound by tight junctions 
that separate the sinusoidal space from the bile canaliculi. Endothelial cells 
line the sinusoids.Between adjacent hepatocytes lie the bile canaliculi that 
empty into bile ductules located in the portal spaces. Hepatocytes are thus 
polarized and bound by three membrane domains: the lateral membrane 
between adjacent hepatocytes, the basolateral membrane that abuts the 
Sinusoidal space and the apical or canalicular membrane. Endothelial cells 
in the liver are very specialized. They have pores measuring almost 1 μm in 
diameter. This is a very large area considering that a red blood cell measures, 
on average, 6 μm in diameter. These fenestrated endothelial cells that lack 
basement membranes facilitate rapid exchange of substances between 
plasma and hepatocytes. Hepatocytes have microvilli on the sinusoidal 
plasma membrane, which facilitate the exchange of nutrients. In addition, 
the low pressure and slow blood flow further enhance bidirectional transfer 
of solutes. Between endothelial cells and the hepatocytes are narrow spaces 
called the spaces of Disse, which interconnect and drain into the lymphatic 
vessels that are located in the portal areas. Hepatic lymph is formed when 
there is increased sinusoidal pressure, especially with obstruction to the 
outflow of blood from the liver. This lymph may accumulate as ascites. Two 
other cell types found around the sinusoidal space include the Kupffer and 
the stellate cells. The stellate cell, also known as a fat storage or Ito cell, is a 
major site for vitamin A storage and can be identified by its high lipid 
content. Relevant to disease, the stellate cell is the major cell type associated 
with the development of hepatic fibrosis in response to liver injury. With 
liver injury, stellate cells become activated to a myofibroblast-like state, 
which is associated with collagen gene expression, reduction of vitamin A 
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content and morphologic changes. Kupffer cells are prominent in the 
sinusoids, macrophage derived, and the principal phagocytic cells of the 
liver. Kupffer cells are important mediators in the inflammatory response in 
the liver. 
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 AIMS OF STUDY: 
1. To analyze the epidemiology of choledochal cyst related to age, 
sex and type.  
2. To analyze various clinical presentations of choledochal cyst. 
3. To discuss the role of ultra-sonogram in the diagnosis and follow 
up of patients. 
4. To analyze the length of common channel by a preoperative 
MRCP. 
5. To correlate intraoperative biliary amylase levels with the type of 
choledochal cyst 
6. To discuss various complications of choledochal cyst after 
operative treatment.  
 
PATIENTS AND METHODS:  
 
• All patients presenting to the paediatric surgical department between 
Jan 2008 to Jan 2011 treated at Institute of child health, Egmore were 
included in the study. The median age was 5 years (range: 4months to 
12 years). The male to female ratio is 1:2. 
 
• All patients underwent surgery after complete investigations and 
evaluation. 
 
• The study was designed as a case cohort report. Data were registered 
using patient’s files, operative reports and office notes. The following 
data were collected: presenting symptoms, complications of disease, 
diagnostic strategy and treatment of choledochal cysts. 
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• Patients were subdivided into 3 age groups: Group A, patients below 2 
years of age. Group B patients from 2 - 9 years of age and Group C 
patients from 10 - 13 years. 
 
• Statistical significance of the results was evaluated. 
 
• Analyses of clinical features in symptomatic children were done and 
an epidemiological study carried out. 
 
• All baseline investigations were carried out. 
 
• Special investigations like liver function tests, clotting profile and 
urinary urobilinogen were also carried out. 
 
• An epidemiological study of the type of cyst, length of common 
channel, sex incidence with the type is made. 
 
• A correlation between intraoperative type of the cyst and the type by 
MRCP is done. (Hirayukie et al, 42) 
 
• The length of the common channel and it’s correlation to the cyst type 
is made. A common channel length of more than 2cms is taken as an 
anomalous pancreaticobiliary duct junction. (Komi et al, journal of 
paed. surg 1992.) 
 
• Assessment of cirrhosis was done both by ultrasound and by 
intraoperative assessment. 
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• After stabilization and a proper anesthetic assessment patients were 
subjected to surgery depending on the type. 
 
• Intraoperative biliary fluid from the cyst was taken and sent for 
analysis of amylase levels.(Tan KC et al,BJS, 1988) 
 
• Patients were kept in the postoperative ward and were given broad 
spectrum antibiotics. 
 
• A study of the postoperative complications namely cholangitis, 
intrahepatic calculi, adhesive obstruction, pulmonary complications 
and anastomotic leak are made. 
 
• A correlation between a hepaticodochoduodenostomy or a 
hepaticodocho roux- en- y jejunostomy and the postoperative outcome 
was also studied. 
 
• Finally, serial ultra-sonogram evaluations were done at discharge and 
subsequently to look for residual IHBR dilatation. 
 
All data were entered and an analysis done.  
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OBSERVATION AND RESULTS: 
Table 1 shows presenting symptoms with subdivision into the age groups. 
Abdomen pain is the most frequent symptom (30 of 30 patients, 100%) with 
a significantly higher incidence in the 2-9 years group (19 out of 19 patients, 
p<= 0.05). 
Jaundice is the main presenting symptom in 2-9 years age group (9 out of 19 
patients,47%) with a statistical significance of p<0.05. overall we found 
pancreatitis in 4 of the 30 patients studied and cholangitis in 2 of 30 patients. 
Although not significant, pancreatitis was found in age group between 2 to 9 
years. (4 of 19 patients, 21%). Both the category of patients who had 
pancreatitis and cholangitis were treated conservatively in the ward with 
intravenous antibiotics and antisecretory agents like somatostatin analogue 
and then were taken up for surgery after a median period ranging from a 
week to ten days. All the patients who had clinical features suggestive of 
pancreatitis had serum amylase done (8 patients) of which 4 had showed an 
elevated serum amylase and hence considered to have associated pancreatitis. 
                    
 TABLE 1: symptoms and age. 
Symptoms Total(n=30) Group 
A(n=5) 
Group 
B(n=19) 
Group 
C(n=6) 
Pain 30 5 19 6 
 
Jaundice  13 2 9 2 
 Mass 5 0 5 0 
Acholic stools 4 1 3 
 
0 
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Hepatomegaly 15 2 12 1 
Cirrhosis 3 0 3 0 
Others 3 0 3 0 
 
 
Table 2 shows the presenting symptoms compared with the type of 
cyst. Abdomen pain is the main symptom in most types. No case of type 
3 was reported in my study. No case of antenatally detected choledochal 
cyst was reported in my study. 
          TABLE 2: Presentation and cyst type. 
Symptom Type1 
(n=22) 
Type2 
(n=4) 
Type3  
(n=0) 
Type4 
(n=4) 
Type5 
(n=0) 
Total 
(n=30) 
Pain 20 2 0 4 0 30 
Jaundice 7 1 0 2 0 13 
Mass 4 1 0 0 0 5 
Acholic stools 1 0 0 2 0 4 
Hepatomegaly 10 0 0 3 0 15 
Cirrhosis 0 0 0 1 0 3 
Others 0 0 0 2 0 3 
 
 
 
 
 
 
 
19 
 
Table: 1 Symptoms and age 
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Table: 2    Presentation and cyst type 
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The classic triad of pain, mass and jaundice was seen in none of 
the patients studied. 
Diagnostic procedures: 
The following studies were performed: ultrasound scan abdomen 
(30 of 30 patients, 100%), MRCP in 29 of 30 patients (99%). Abdomen x 
ray was taken but inconclusive.  Laparoscopy was not performed in all 
cases. 2 patients underwent gastroduodenoscopy (2 of 30 patients) [7%]. 
Serum amylase was not routinely performed in all cases, was done in 8 of 
30 patients (24%). Cyst biliary amylase was done in 29 of 30 patients 
studied (99%). 
Diagnosis: 
Table 3 shows the types of cysts among the study group. The 
majority of the cysts were extra hepatic, mostly type 1 cyst. 22 of 30 
patients (72%) 
       TABLE 3: Type of cysts. 
Type Total(n= 
30) 
Group A(n=4) GroupB(n=2
0) 
GroupC(n=6)  
1 22 3 13 6 
2 4 1 3 0 
3 0 0 0 0 
4 4 0 4 0 
5 0 0 0 0 
Carcinoma 0 0 0 0 
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TABLE: 3   Type of cysts 
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The incidence in descending order is type1 followed by type3 and finally 
type4. All the cases had a formal histopathological examination of the 
cysts.27 of 30 patients had chronic inflammation and fibrosis whereas 3 
patients had shown epithelial desquamation with minimal inflammation 
(Komi et al). No case in my study showed any evidence of metaplastic 
changes.  No case of cholangiocarcinoma was reported in the study. 
Length of common channel and type: 
29 of the 30 patients had undergone an MRCP and the length of 
the common channel measured as shown in table 4. 
         Table 4:  Length of common channel. 
Type <2centimeters(n=9) >2centimeters(n=20) 
1 8 14(4 patients had 
preoperative pancreatitis). 
2 1 3 
3 0 0 
4 0 3 
5 0 0 
 
A long common channel was seen in 20 of 29 patients (>=2 cms), which is 
67% of patients under study, whereas only 9 of 29 patients (34% of patients 
under study) had a common channel <2 cms as shown in table 4. 
Analyzing table 4, no patient in type 4 had a short common channel. 
(Statistical significance being high p<=0.05). Type 1 patients had almost equal 
distribution with 8 of 22 patients (40%) (Statistical significance p<0.05) having 
a short common channel whereas 14 of 22 patients (70%) (Statistical 
significance p<0.05) had a long common channel . 
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Table 4:  Length of common channel 
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ULTRASOUND OF CHOLEDOCHAL CYST
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MRcholangiopancreatogram shows markedly dilated 
common bile duct (large straight arrows) without 
intrahepatic bile duct dilatation (curved 
arrows).Diagnosis of type I choledochal cyst was easily 
made. Small straight arrows = gallbladder. 
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OPERATIVE SPECIMEN OF CHOLEDOCHAL CYST.
28 
 
 
 
 
 
 
 
 
 
 
Type 2 choledochal cyst by an MRCP and CT 
ABDOMEN  picture.
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MRCP PICTURE OF TYPE 1 CHOLEDOCHAL CYST. 
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             MRCP PICTURE OF TYPE 4 CHOLEDOCHAL CYST. 
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OPERATIVE PICTURE - CHOLEDOCHAL CYST . 
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3D RECONSTRUCTED IMAGE OF TYPE I CHOLEDOCHAL 
CYST BY MRCP.
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             OPERATIVE PHOTOS 
               
       TYPE 1 CYST 
 
               
 
       HEPATIC DUCTS
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      COMPLETED HEPATICO JEJUNOSTOMY 
 
              
 
         COMPLETED JEJUNOJEJUNOSTOMY
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The choledochal cyst (thin arrow) and 
Gallbladder (thick arrow) demonstrated with magnetic 
Resonance imaging cholangiography. 
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The choledochal cyst (thin arrow) demonstrated 
with magnetic resonance imaging cholangiography. 
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Treatment: 
Most patients underwent a resection with either a 
hepaticoduodenostomy or a hepaticojejunostomy as shown in table 5. 
This consisted of resection of extra hepatic cyst (type1, 2 and extra 
hepatic part of type 4a) with reconstruction of a biliary digestive 
anastomosis by a Roux-en- Y loop in majority of these patients. (73%). 
   TABLE 5:  Anastomosis and cyst type. 
Anastomosis 1(n=22) 2(n=4) 3(n=0) 4(n=4)
* 
5(n=0) Total(n= 
29) 
Hepaticoduod
enostomy 
4 1 0 1 0 6 
Roux –en-Y 18 3 0 2 0 23 
          *One patient did not undergo surgery. 
 23 out of 29 patients (76%) underwent hepaticojejunostomy whereas 6 of 
29 patients (24%) underwent hepaticoduodenostomy. 
 
Procedure related complications: 
Procedure related complications were seen in 9 of the 29 patients (30%). The 
complications consisted of adhesive intestinal obstruction (3 patients), 
cholangitis (2 patients) and pancreatitis in 3 patients which are shown in 
table 6 below. 
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 TABLE 5:  Anastomosis and cyst type 
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TABLE 6: Surgery related complications. 
 
Complications Hepaticoduodenostomy Hepaticojejunostomy 
Adhesive obstruction 3 0 
Pancreatitis 0 3 
Cholangitis 1 1 
Biliary leak 3 1 
 
 
All 3 patients who underwent hepatico duodenostomy had 
adhesive intestinal obstruction, all 3 being treated conservatively in 
the ward, none being reopened. All patients who had postoperative 
pancreatitis belonged to the hepaticojejunostomy group and all these 
patients were treated conservatively with intravenous antibiotics and 
somatostatin and all recovered well. 2 patients each in either group 
had cholangitis. Immediate post-operative biliary leak was found in 3 
of the hepatico duodenostomy group and in 1 of the hepatico 
jejunostomy group. All the patients with leak were managed 
conservatively. It is interesting to note that all those patients who had 
biliary leak in the hepaticoduodenostomy group had adhesive 
obstruction later. 
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Sensitivity of MRCP: 
Out of 29 patients who underwent MRCP, only 3 patients had 
discordant findings intraoperatively. 26 out of 29 patients (100% 
sensitivity, 90% specific) had correct intraoperative anatomy as was 
delineated by MRCP preoperatively. Apart from detecting a 
choledochal cyst as said above MRCP detected a long common 
channel in 20 of 29 patients (65%) as shown in table 4.  
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TABLE 6: Surgery related complications 
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Cyst amylase and type: 
A biliary amylase level between 35-150 IU was found in 17 
patients of type1 group (17 out of 20 patients, 85%) whereas a very 
high value >150 was found in 4 of 20 patients (20%). 
All patients belonging to type 4 group had gross elevation of 
biliary amylase levels as shown in table 7. 
Rest of the types had normal or subnormal cyst amylase levels. 
   
 
 
TABLE 7: Cyst amylase and type: 
Type 35-150 >150 <35 
1 17 4(presented with 
pancreatitis and 
had a long 
common 
channel) 
1 
2 3 1 0 
3 0 0 0 
4 0 3 0 
5 0 0 0 
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TABLE 7: Cyst amylase and type 
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DISCUSSION: 
In this study more than half of the patients belonged to age group 
of 2-9 years which is in accordance with literature (32). The type of 
symptoms depends largely on age at presentation. Abdomen pain has 
been reported to be the most frequent symptom at presentation which was 
also found in our series (32). Jaundice is reportedly the main symptom in 
2-9 years age group in my study as against found commonly in infants in 
other series (33). No case of antenatally detected choledochal cyst was 
reported in my study. 
  It has been suggested that age related differences in 
presentation is determined by whether there is reflux of activated 
pancreatic juice into the biliary tree(10). It was found that patients with 
abdomen pain were older than two years and that there is a relation with 
elevated biliary amylase and signs of chronic inflammation on 
intraoperative dissection in my study. 
  The findings of jaundice as the main presenting symptom 
of extra hepatic cysts was same as earlier reports (34,35) but the higher 
incidence of cholangitis and gall stones in intrahepatic cysts was  not 
noted in my study(34,35). This may be explained by localization of the 
lesion. Extra hepatic cysts may cause complete obstruction of biliary tree 
leading to jaundice. 
  The classic triad of abdomen pain, jaundice and abdomen 
mass was not seen in any of my cases. This is in accordance with the 
literature. (29, 32). 
In most patients ultrasound scan is the primary imaging technique 
for detection of choledochal cysts and usually to establish the diagnosis 
(36).  MRCP is mandatory to define the precise anatomy (37) as was 
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performed in most of our patients. Although there is no higher risk of 
complications (38), invasive cholangiography was less frequently 
performed in children. More recently, MRCP has become available and 
as a noninvasive method, is a promising alternative (39). CT may be of 
help in patients with intrahepatic cysts and patients suspected of 
malignancy (32).Plain abdomen films, laparoscopy and 
gastroduodenoscopy are not used as standard diagnostic tools for 
choledochal cysts and were mainly performed during work up of patients 
with associated gastric symptoms. 
  Like in most series, the majority of the patients had type 
1 cyst (32). Because the necessary information was not available, a 
further subdivision of type 1 cysts into cystic and fusiform cysts, as used 
by other investigators (29) was not possible in this series.  
  MRCP is 100% sensitive in detecting choledochal cysts 
and almost 90% specific in diagnosing choledochal cyst anatomy. Table 
8 shows the value of MRCP in detecting the length of common channel. 
As shown in table 8 MRCP is 65% sensitive in detecting a long common 
channel in our study. 
 Table 8: MRCP and long common channel. 
Detected  Undetected  
20/29 (65%) 9/29(35%) 
 
MRCP provides the best projection image for showing the extent 
of choledochal cyst as well as the best choice for use in surgical planning. 
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TABLE 8: MRCP and long common channel 
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The most common complication associated with a choledochal cyst 
is the presence of stones in biliary tree (16). The value of MRCP in 
diagnosing choledocholithiasis has been well documented with high 
sensitivities and specificities of more than 90% reported (40). Although 
this is a small subject group, one patient had choledocholithiasis and 
none had hepatic stones. One case had a spontaneous bile duct 
perforation which was diagnosed intraoperatively and treated accordingly. 
The anamolous junction of the pancreatico biliary duct is believed 
to represent one cause of choledochal cysts (9). In a study by komi et al 
(17), the type of anamolous junction of pancreaticobiliary influenced the 
outcome of patients with choledochal cysts who underwent cyst excision 
and bile duct reconstruction. Ohkawa et al (10) reported six cases of 
dilated common channels with and without choledochal cyst termed as 
“common channel syndrome” that ensured severe complications if left 
untreated. Thus evaluation of both the anamolous junction of pancreatico 
biliary duct and the dilated common channel is crucial when examining 
choledochal cysts. 
In our study the presence of both the anamolous junction and the 
long common channel was diagnosed correctly on MRCP. Although the 
number of patients was small, I believe that, in general, the presence of 
anamolous junction of the pancreaticobiliary duct can be diagnosed 
correctly on MRCP, because, using a half-Fourier acquisition single shot 
turbo spin- echo sequence, MRCP can visualize the common bile duct 
and main pancreatic duct of normal size in patients(41). MRCP using the 
above mentioned technique has a maximum resolution of 1 mm (41). 
However the special resolution is considered to be insufficient for 
pediatric patients as reported in a study by Hiroyuki Ire et al (42), but 
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Hirohashi et al (43) reported that the anamolous junction of pancreatico 
biliary duct was identified in four of the five pediatric patients with 
choledochal cysts. Since there were many researchers who say that value 
of MRCP is a bit inferior in pediatric patients compared to adults, in 
evaluating choledochal cysts, further refinements in MRCP techniques 
are required for examining pediatric patients- especially infants-with 
choledochal cysts. Matos et al (44) reported the usefulness of MRCP 
after secretin stimulation and this method might be useful for evaluation 
of anamolous junction of biliary duct in pediatric patients. 
Regarding malignancy no case of cholangiocarcinoma was 
reported in my study over a 3 year period. No case of malignancy was 
reported in adults who underwent complete excision of the cyst. 
Malignancies were reported when internal diversion was done. (48). 
Regarding biliary amylase levels aspirated from the cyst, it is not a 
sensitive marker as only 20% of patients in type 1 had an elevated 
amylase levels. These patients also had an elevated serum amylase levels, 
probably due to associated pancreatitis in these patients. Rest of the types 
had a normal biliary amylase levels except type 4 where 100% of patients 
had elevated levels possibly explained by multiple extra hepatic and 
intrahepatic cysts with a long common channel causing gross reflux of 
pancreatic juice. 
CORRELATION BETWEEN CYST AMYLASE, COMMON 
CHANNEL AND PANCREATITIS: 
As shown in table 4 and table 7, all 4 patients who had pancreatitis 
preoperatively belonged to the type1 with long common channel and all 
these 4 patients had an elevated cyst amylase levels and is a statistically 
significant correlation.(p<=0.05, 100%). 
49 
 
TREATMENT OF CHOLEDOCHAL CYSTS- DISCUSSION: 
The concept of treatment of extra hepatic choledochal cysts has 
changed in the past 20 years because of a persistent high risk of 
malignancy after drainage procedures (18). In addition a high rate of 
benign complications, mainly anastomotic strictures, of internal drainage 
procedures has been reported (45). In view of the high risk of 
cholangiocarcinoma, the state of the art treatment of extra hepatic 
choledochal cysts is primary excision (46, 32) with construction of a 
biliary digestive anastomosis. Type 3 cysts remain an exception to these 
guidelines, because the risk of carcinoma is considered low (32), these 
patients are effectively treated by endoscopic sphincterotomy (47). No 
case of type 3 is reported in my study.  
The treatment of our patients is in accordance with this policy. 
Currently, excision of extra hepatic cysts and a bilio digestive 
anastomosis is recommended even in the absence of symptoms(18,46). 
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REVIEW OF LITERATURE: 
 
The first description of choledochal cyst is attributed to Vater (1) in 1723. 
Douglas (2) provided one of the earliest and the best clinical description 
of a choledochal cyst of the common bile duct in 1852. Alonso-lej (3) in 
1959 published an excellent review and introduced a simple classification 
of choledochal cyst.Flanigan reported 955 cases of this fascinating entity 
throughout the world in literature (4). Now more than 3000 cases have 
been reported in literature (1, 4). 
Incidence: 
Although the true incidence of choledochal cyst is unknown it is clear 
that there is a marked racial variation. The highest rates are seen in the 
Chinese and Japanese (5). Although about 60% of cases are diagnosed in 
the first ten years of life, an initial presentation in adult life is unknown. 
(6, 7). There is a marked female preponderance of about 4:1 in most 
series whatever the racial origin. 
Etiology: 
There have been numerous hypothesis put forward to explain the etiology 
of choledochal cyst. These can be classified into three categories. 
1. Obstruction of the distal common bile duct causing dilatation (8). 
2. Congenital weakness of the bile ducts. 
3. Reflux of pancreatic juice into the biliary tree via an abnormal 
pancreaticobiliary junction (9). 
Choledochal cysts have been produced experimentally by removing 
epithelium and ligating the distal portion of bile ducts in puppies and also 
by anastomosing the pancreatic duct directly to the biliary tract. [10]. 
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Abnormally high levels of amylase are frequently found in bile taken 
from choledochal cysts [11] and this is believed to occur because of 
reflux through the abnormal biliary and pancreatic ducts proximal to 
ampulla of Vater. This abnormality produces a common biliary 
pancreatic channel which is at least 2cms in length. [12]. In fetal life the 
pancreatico biliary junction lies outside the duodenum and migrates into 
the wall to lie within the sphincter complex before birth. [13]. Arrest of 
this process may be the cause of the common channel anomaly. Several 
studies [1, 9, and 14] have suggested that choledochal cysts may be 
caused by an anomalous angle of entry of the common bile duct into 
ventral pancreatic duct creating a long common channel.  
Dysfunction of sphincter of oddi allows reflux of pancreatic juices into 
the common bile duct [14]. This is thought to cause enzymatic bile duct 
injury and bile duct dilatation. Common channels, although seen 
occasionally a normal variant, are also associated with other pathological 
conditions such as gall bladder cancer. In one of the series a common 
channel was identified in 1.5% of ERCP of which 18 of 24(75%) were in 
patients with choledochal cysts and 4 of 24(16.6%) had gallbladder 
carcinoma. [16]. Approximately  60-70% of choledochal cysts can be 
shown to have a common channel and Komi et al[17] have devised a 
complex classification based on anomalous pancreatico biliary junction 
based on the radiographic appearances of 51 cases of choledochal cysts. 
They also suggested that certain subtypes may also lead to chronic 
pancreatitis even following appropriate surgery for cystic disease. 
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Pathological features: 
The most widely accepted classification of choledochal cyst was first 
described by Alonso-lej et al [5] in 1959 and modified by Todani et al 
[18] in 1977. The commonest variant is the type1 cyst which describes 
dilatation of common bile duct proximal to a narrow segment of distal 
common bile duct. Type1 cysts are subdivided into cystic (50%) or 
fusiform (10%) variants based on external morphology. Intrahepatic 
ducts may or may not be involved in the dilatation. 
Classification of choledochal cyst: 
Type 1- 1a cystic dilatation (51%) 
- 1b fusiform dilatation (10.6%) 
    Type 2 - Diverticulum 
    Type 3 – choledochocele (dilatation of intraduodenal part of CBD) 
    Type 4 – 4a extra hepatic cysts 
   - 4b intrahepatic cysts (28.5%) 
    Type 5 – intrahepatic dilatation alone (4.6%)  
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 A type 2 cyst is a congenital diverticulum of the common bile duct. It is 
very rare and only five genuine examples have been reported. [19] Type 
3 cysts are also known as “choledochocele” and are dilatation of 
intraduodenal part of common bile duct. [20]. They may be associated 
with recurrent jaundice and are best diagnosed by ERCP. Type 4 cysts 
involve both intra and extra hepatic biliary tree whereas type 5 cysts are 
confined to the liver substance itself. The latter two may be complicated 
by portal hypertension and cirrhosis. [13]. 
                             Caroli’s disease [21] refers to a condition in which 
there are multiple, bilateral, irregular dilatation of intrahepatic bile ducts. 
Unlike other types, it may be associated with hepatic fibrosis and cystic 
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disease of kidneys. This condition is not, however, related to polycystic 
disease of the liver, in which the cysts do not communicate with the 
biliary tract and contain mucus rather than bile.  Caroli defined two types 
of intrahepatic dilatation, a rarer form which is not associated with 
cirrhosis and portal hypertension and a commoner type associated with 
congenital hepatic fibrosis and usually presenting in childhood. 
Medullary sponge kidneys and occasionally Lawrence- Moon –Biedl 
syndrome.  
Histologically the wall of a choledochal cyst is partially replaced by 
chronic inflammation and fibrous tissue and the epithelial lining may be 
totally or partially absent. In a study of the age related effects on 40 
choledochal cysts, Komi et al [22] stated that under two years of age 
there is epithelial desquamation and fibrosis but minimal inflammation; 
by the age of 15 years an epithelial lining could not be identified in 
majority of the cysts and in those excised from adults there were 
pronounced metaplastic changes. Shimada et al [23] recently suggested a 
biochemical mechanism for these changes when they observed high 
levels of phospholipase A2 in bile from cases with common channel. The 
mediator produces a cytotoxic phospholipid which may cause direct 
damage to bile duct mucosa. A histological appearance of the liver varies 
from mild inflammatory infiltration to frank biliary cirrhosis. Portal 
hypertension and esophageal varices may occur and these uncommon 
complications have been seen in an infant of three months [11]. 
Clinical features: 
The classic presentation of pain, mass and jaundice varies in incidence 
from series to series. It is not however a universal presentation (Table A) 
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and was present in only 38% of cases collected by Flanigan [4] and in 
only 25% of series from King’s college hospital. [11, 14]. 
 Choledochal cysts in infants present with obstructive jaundice a picture 
indistinguishable from biliary atresia and intrahepatic causes of neonatal 
cholestasis. [26]. 
Choledochal cysts should always be considered in an older child who 
presents with recurrent abdomen pain and a raised serum amylase [27, 
28] as pancreatitis is a well-recognized complication of common channel. 
The refluxing amylase may be absorbed through cyst wall to cause 
hyperamylasaemia. Recurrent abdomen pain may be associated with high 
levels of serum amylase and pancreatitis, although macroscopic 
pancreatic changes may not be very obvious at laparotomy. Stringel and 
filter [29] have described this lack of pancreatic change at operation as 
“fictitious pancreatitis”. 
Uncommon presentations include spontaneous and traumatic rupture [30, 
31], rupture during pregnancy, dysfibrinogenemia, liver abscess [28] and 
esophageal varices due to cirrhosis. 
CLINICAL PRESENATION: (Table A) 
Common Uncommon 
Jaundice  
Abdomen mass 
Abdomen pain  
Fever 
Acholic stools 
Hepatomegaly 
Vomiting 
Pancreatitis 
Pruritus 
Splenomegaly 
GI bleeding 
Anemia 
Failure to thrive  
Perforation 
Peritonitis 
Portal hypertension  
Dysfibrinogenemia   
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Diagnosis: 
Noninvasive investigations with ultrasound or CT are commonly used 
to confirm the clinical diagnosis and in most cases these are definitive 
tests. (Table B and C). Plain X-rays of the abdomen and barium studies 
of the upper gastrointestinal tract may show duodenal displacement and 
excretion radionuclide scans may also be helpful. However delayed scans 
are needed to demonstrate isotope accumulation in the cysts of jaundiced 
patients. 
Although accurate preoperative anatomical definition of the biliary 
tree may be obtained by percutaneous Trans hepatic cholangiogram or 
ERCP, both being invasive and associated with complications of biliary 
leakage or pancreatitis and are not done as a routine diagnosis. Prenatal 
diagnosis was first reported in 1983 and two cases were diagnosed at 17 
weeks gestation. 
 MRCP is a recent imaging modality introduced in the armamentarium of 
choledochal cyst and is a safe, noninvasive and cost effective alternative 
in evaluating the anatomy of biliary tree. It has gradually replaced ERCP 
in investigating choledochal cyst.  
Investigations: Table B 
Commonly useful  
Ultrasonography 
Computerized tomography 
MRCP 
Occasionally useful 
Plain abdomen x ray. 
Barium meal 
Oral and intravenous cholangiography 
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Hepatobiliary scintigraphy 
Intraoperative cholangiography 
Rarely used 
Laparoscopy 
Angiography  
 
 
 
 
 
 
COMPARISON OF USG, PTC, ERCP AND MRCP IN THE 
DIAGNOSIS OF CHOLEDOCHAL CYST. TABLE C: 
 USG PTC ERCP MRCP 
Invasiveness  -ve +ve +ve -ve 
Technical difficulty -ve -ve +ve -ve 
Image of biliary tree Fragmented Integ
rated 
Integrat
ed 
Integrate
d 
CBD Gas 
interference 
Clear
ly 
seen 
Clearly 
seen 
Clearly 
seen 
Relationship between 
pancreatic and biliary 
tree 
Not clear Not 
clear 
Clearly 
seen 
Clearly 
seen 
Irradiation  -ve +ve +ve -ve 
Risk of biliary infection -ve +ve ++ve -ve 
Allergy to contrast -ve Rare Rare -ve 
Pancreatitis -ve -ve +ve -ve 
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SURGICAL MANAGEMENT: 
Internal drainage or radical excision has been the two main approaches used 
in the surgical management of choledochal cyst. Most authors have not 
concluded that internal drainage whilst technically easier have unacceptably 
high complication rate in the long term. [55, 56, 57]. It is now recommended 
that except in the unusual situations of acute severe cholangitis or severe 
portal hypertension the treatment of majority of cases should be complete 
cyst excision. 
Surgery is usually performed through an upper abdomen transverse incision. 
[24, 58]. Cholangiography may be performed initially via the gall bladder to 
confirm the extent of both biliary dilatation and intrahepatic involvement in 
smaller cysts. In larger cysts it is unhelpful as the large volume of contrast 
required to fill the cysts obscures the detailed anatomy of distal common bile 
duct. In very young infants it is necessary to exclude biliary atresia which 
may be associated with cystic dilatation in either the proximal or distal 
regions of atretic bile ducts. These cystic segments should not be confused 
with choledochal cysts. Bile is aspirated at the commencement of operation 
and analyzed immediately for amylase contents. A high amylase level would 
indicate the presence of a common pancreaticobiliary channel. 
The choledochal cyst and the gallbladder are dissected free of the hepatic 
artery and the portal vein. The proximal end of the cyst, usually at the level 
of bifurcation of the common hepatic duct, is encircled and then divided. 
This mobilization assists the distal dissection which proceeds to the level of 
pancreas. The narrowed segment of common bile duct is then divided and 
the lower end sutured or ligated. A hepaticojejunostomy using 40cms Roux 
loop of jejunum is used for bile drainage. Occasionally it is prudent to leave 
a portion of distal cyst wall because of inflammation and scarring but the 
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mucosa in the distal portion of the cyst can be removed by sub mucosal 
dissection. [59]. 
Endoscopic / operative sphincterotomy has been used in some cases of 
fusiform choledochal cyst. Ng et al [60] reported good results in 5 of 6 
children subjected to endoscopic sphincterotomy but with a mean follow up 
of only 4 years. They suggest that endoscopy should be restricted to children 
with mild fusiform dilatation and a distal stenosis. Although there are 
theoretical objections because of long term risk of malignancy Todani et al 
[61] have suggested that carcinoma seldom, if ever develops in the fusiform 
type. But a few centres are in favor of sphincterotomy approach to treatment 
in patients who possess a common channel as risk of future attacks of 
pancreatitis and cholangitis remains. [58]. 
Other rarer variants of these choledochal anomalies may require more 
individualized surgery. Type 2 choledochal cysts can be treated by excision 
of the diverticulum and reconstruction of bile duct. [19]. Type 3 cysts 
(choledochocele) can be removed via a Trans duodenal approach [62] or be 
ablated by endoscopic sphincterotomy. [20].The management of intrahepatic 
cystic disease is more complex. If the cystic disease is localized to one lobe 
then this can be excised completely as a formal hepatic lobectomy. [63]. If 
the intrahepatic biliary dilatation is combined with extra hepatic dilatation 
then radical excision of biliary tree and Roux loop reconstruction should 
improve biliary drainage. Long term follow up is mandatory as intrahepatic 
cysts may develop complication including stone formation and malignant 
change. [65]. 
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Complications: 
TABLE OF COMPLICATIONS: 
Early        Late 
Anastomotic leakage    cholangitis  
Small bowel obstruction    pancreatitis 
Biliary cutaneous fistula             portal hypertension  
Sepsis                GI bleeding 
       Choledocholithiasis 
       Gall stones 
       Cirrhosis 
       Malignancy  
A few patients who have undergone cyst excision and hepatico-jejunostomy 
may present with a late recurrence of pancreatitis. This may be secondary to 
proximal pancreatic duct or sphincter stenosis, pancreatic duct calculi or 
congenital anatomic anomalies of the pancreatic ducts. Examination with 
ERCP is imperative in these cases and sphincterotomy may relieve the 
symptoms. 
Carcinomatous change may occur in choledochal cysts, particularly in adults. 
The increased risk has been calculated as between 5 and 35 times more than 
cholangiocarcinoma in undilated ducts. [18,64]. However, malignancy may 
occur in children and Lawai et al[65] recently reported a 12 year old girl 
with adenocarcinoma of a distal cyst wall. Flanigan [67] reviewed 24 cases 
of malignant change and suggested an overall incidence of 2.5%. 
Histologically these tumors may be either adenocarcinoma or squamous cell 
carcinoma. The prognosis is poor following the development of carcinoma 
and Kagawa et al [68] described 47 cases where the average survival was 
only 8.5 months. The cause of metaplastic and neoplastic change is still not 
61 
 
understood but stasis and bacterial overgrowth generate secondary bile acids 
which may be mutagenic. [64]. All biliary mucosa is at risk of neoplastic 
change and this is not reduced by simple drainage procedures. 
Conclusion: 
Choledochal cyst is a rare surgical condition that requires early diagnosis 
and prompt surgical treatment to prevent biliary cirrhosis and portal 
hypertension. 
Preferred surgical management is: 
Cyst excision and anastomosis of common bile duct to a 40 cm Roux-
en-y jejunal loop. 
Other modalities which are obsolete or that are performed rarely are: 
1. Direct anastomosis of the cyst to a 40 cm Roux-en-y jejunal loop. 
2. Internal drainage procedures whilst technically easier have an 
unacceptably high long term complication rate. 
3. Endoscopic or operative sphincterotomy is useful in case of 
choledochocele.   
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CONCLUSION: 
1. Choledochal cysts are resected more often in childhood. 
Presenting symptoms are age dependent with abdomen pain 
predominating in all age groups with male to female ratio of 1:2. 
2. Biliary amylase levels are a sensitive marker in detecting type 4 
cysts (100%) but not in other types (table7). 
3. Ultra sonogram is the major diagnostic tool and a highly 
sensitive investigation in picking up choledochal cysts and its 
accuracy is increased when accompanied by MRCP. 
4.  MRCP appears to offer diagnostic information that is 
equivalent to that of ERCP. It is a first choice imaging 
technique for examination of pediatric patients with 
choledochal cysts 
5. A preoperative finding of pancreatitis with a long common 
channel by MRCP correlates well with an elevated cyst amylase 
in my study and is 100% diagnostic in supporting the theory of 
long common channel proposed by Babbitt et al. 
6. Total excision of the cyst with hepaticojejunostomy is the 
preferred surgical treatment and is well tolerated with minimal 
complications and there was no mortality in the group. 
7. Whereas post-operative pancreatitis is more common with the 
hepaticojejunostomy group, adhesive obstruction and biliary 
leak is more common with the hepaticoduodenostomy group. 
8. In view of high risk of cholangiocarcinoma, complete resection 
and not internal drainage is the appropriate treatment of type1, 
2 and the extra hepatic part of type 4 biliary cysts. 
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PROFORMA; 
 
• AGE INCIDENCE. 
• SEX INCIDENCE 
• TYPE DISTRIBUTION 
• PRESENTATION SYMPTOMS: 
• Pain 
• Jaundice 
• Mass 
• Acholic stools.  
• Other symptoms 
• SIGNS: 1.hepatomegaly 2.cirrhosis 
• POSTOP.COMPLICATIONS:1.cholangitis2.anastomotic leak 
3.adhesive obstruction 4.pulmonary infection 5.intrahepatic calculi 
6.none. 
• COMMON CHANNEL LENGTH AND PANCREATICOBILIARY 
DUCTAL MALUNION TYPE: 
• BILIARY AMYLASE AND TYPE: 
• OUTCOME OF 
HEPATICODOCHODUODENOSTOMY/HEPATICODOCHO 
ROUX-N-Y JEJUNOSTOMY 
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